These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6127066)

  • 61. U-74500A (lazaroid), a 21-aminosteroid attenuates neuroleptic-induced orofacial dyskinesia.
    Bishnoi M; Chopra K; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 2007 Nov; 29(9):601-5. PubMed ID: 18193111
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Parkinsonism following neuroleptic withdrawal.
    Nelli AC; Yarden PE; Guazzelli M; Feinberg I
    Arch Gen Psychiatry; 1989 Apr; 46(4):383-4. PubMed ID: 2564765
    [No Abstract]   [Full Text] [Related]  

  • 63. Dopamine D2 receptors in demented patients with severe neuroleptic sensitivity.
    Piggott MA; Perry EK; McKeith IG; Marshall E; Perry RH
    Lancet; 1994 Apr; 343(8904):1044-5. PubMed ID: 7909079
    [No Abstract]   [Full Text] [Related]  

  • 64. Drug-induced Parkinsonism and idiopathic Parkinson's disease.
    Goetz CG
    Arch Neurol; 1983 May; 40(5):325-6. PubMed ID: 6133514
    [No Abstract]   [Full Text] [Related]  

  • 65. Neuroleptic-induced parkinsonism: impaired potentiation of the H-reflexes.
    Bartels M; Maltzahn DV; Mezger G
    Electromyogr Clin Neurophysiol; 1982; 22(1-2):9-20. PubMed ID: 6121699
    [No Abstract]   [Full Text] [Related]  

  • 66. Critique of DSM-IV: associated features of neuroleptic-induced parkinsonism.
    Segraves T; Abdel-Dayem M
    Am J Psychiatry; 1996 Jun; 153(6):844. PubMed ID: 8633713
    [No Abstract]   [Full Text] [Related]  

  • 67. Severe parkinsonian symptom development on combination treatment with tacrine and haloperidol.
    McSwain ML; Forman LM
    J Clin Psychopharmacol; 1995 Aug; 15(4):284. PubMed ID: 7593712
    [No Abstract]   [Full Text] [Related]  

  • 68. Clinical characteristics of neuroleptic-induced parkinsonism.
    Hassin-Baer S; Sirota P; Korczyn AD; Treves TA; Epstein B; Shabtai H; Martin T; Litvinjuk Y; Giladi N
    J Neural Transm (Vienna); 2001; 108(11):1299-308. PubMed ID: 11768628
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Risk factors for drug-induced parkinsonism in tardive dyskinesia patients.
    Hansen TE; Brown WL; Weigel RM; Casey DE
    J Clin Psychiatry; 1988 Apr; 49(4):139-41. PubMed ID: 2895762
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Postexcitatory inhibition after transcranial magnetic stimulation of the motor cortex in patients with drug-induced parkinsonism and in healthy individuals.
    Masur H; Althoff S; Erim Y; Oberwittler C; Hornung WP
    Int Clin Psychopharmacol; 1998 Mar; 13(2):79-82. PubMed ID: 9669188
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tardive dyskinesia: are first signs reversible?
    Quitkin F; Rifkin A; Gochfeld L; Klein DF
    Am J Psychiatry; 1977 Jan; 134(1):84-7. PubMed ID: 12666
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Self-perception of tardive dyskinesia and neuroleptic-induced parkinsonism: a study of clinical correlates.
    Lohr JB; Lohr MA; Wasli E; Hilliard B; Larson L; Vardiman E; Wade L; Jeste DV
    Psychopharmacol Bull; 1987; 23(1):211-4. PubMed ID: 2885888
    [No Abstract]   [Full Text] [Related]  

  • 73. [Drug-induced parkinsonism].
    Levin OS; Shindriaeva NN; Anikina MA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8):76-81. PubMed ID: 23096050
    [No Abstract]   [Full Text] [Related]  

  • 74. Seborrheic dermatitis: a newly reported side effect of neuroleptics.
    Binder RL; Jonelis FJ
    J Clin Psychiatry; 1984 Mar; 45(3):125-6. PubMed ID: 6142036
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Drug-induced parkinsonism and tardive dyskinesia in nonpsychiatric patients.
    Grimes JD
    Can Med Assoc J; 1982 Mar; 126(5):468. PubMed ID: 6121618
    [No Abstract]   [Full Text] [Related]  

  • 76. Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions.
    Dean CE; Kuskowski MA; Caligiuri MP
    J Clin Psychopharmacol; 2006 Dec; 26(6):560-5. PubMed ID: 17110811
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Iatrogenic parkinsonism in Huntington's chorea.
    Moss JH; Stewart DE
    Can J Psychiatry; 1986 Dec; 31(9):865-6. PubMed ID: 2948633
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Persistent drug-induced parkinsonism.
    Aronson TA
    Biol Psychiatry; 1985 Jul; 20(7):795-8. PubMed ID: 4005336
    [No Abstract]   [Full Text] [Related]  

  • 79. Drug-induced parkinsonism.
    Mena MA; de Yébenes JG
    Expert Opin Drug Saf; 2006 Nov; 5(6):759-71. PubMed ID: 17044803
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prolonged drug-induced Parkinsonism.
    Klawans HL; Bergen D; Bruyn GW
    Confin Neurol; 1973; 35(6):368-77. PubMed ID: 4149771
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.